A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

NCT01671488 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped pilot data to be used for upcoming larger trial.

Conditions

Anal Cancer

Interventions

BIOLOGICAL: Treatment
DRUG: 5FU
DRUG: Mitomycin
RADIATION: IMRT

Sponsor

Brown University

Collaborators

[object Object]
[object Object]